Understanding Artemisinin: How This Ancient Remedy Fights Malaria Fast
How Does Artemisinin Work?
Artemisinin is activated inside malaria-infected red blood cells by iron or heme, which are byproducts of the parasite digesting hemoglobin. This activation breaks the compound’s endoperoxide bridge, releasing reactive free radicals. The endoperoxide bridge is essentially a pair of oxygen atoms linked together.
These radicals then:
Damage parasite proteins and membranes
Disrupt redox and proteostasis systems
Alkylate specific targets like PfPI3K
The result is swift and effective destruction of the Plasmodium parasite, particularly at the early ring stage.
Why Modify Artemisinin?
As noted by Heller and Roepe (2019), the natural form of artemisinin has low water solubility and a very short half-life in the human body. To address these limitations, several semi-synthetic derivatives have been developed:
These modifications improve:
Solubility (for injectable or oral use)
Bioavailability
Pharmacokinetic properties (slightly extended half-life)
Clinical flexibility (used in both severe and uncomplicated malaria)
The result is a family of artemisinin-based drugs suited for different routes of administration and treatment settings.
Half-life: Why Combination Matters
Despite these improvements, artemisinin derivatives still clear the body within 1 to 3 hours, making them unsuitable for monotherapy. That’s why they are combined with longer-acting partner drugs like lumefantrine or piperaquine in Artemisinin-based Combination Therapies (ACTs)—which reduce treatment failure and delay resistance.
Quick Science Note: 10⁻⁸ M = 10 nM
When testing artemisinin in the lab, a concentration of 10⁻⁸ M equals 10 nanomolar (nM)—a common range for assessing antimalarial potency in vitro.
Conclusion
Artemisinin is a sesquiterpene lactone with a reactive endoperoxide bridge.
It kills malaria parasites rapidly by producing toxic radicals inside infected cells.
Derivatives like artesunate and artemether improve its solubility, potency, and pharmacokinetics.
Due to its short half-life, artemisinin is always used in combination therapy to ensure full clearance of the parasite and prevent resistance.
Reference
📚 Citation: Heller, L. E., & Roepe, P. D. (2019). Artemisinin-Based Antimalarial Drug Therapy: Molecular Pharmacology and Evolving Resistance. Tropical Medicine and Infectious Disease, 4(2), 89. https://doi.org/10.3390/TROPICALMED4020089
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments